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This study give a preliminary survey of pharmaceutical contamination and accumulation in surface waters and sediments along
the river Po basin (74,000km2, the largest in Italy), a strategic region for the Italian economy: it collects sewage from a vast
industrialized area of Italy (Autorit` a di Baciono del ﬁume Po, 2006, 2009). 10 pharmaceuticals (atenolol, propanolol, metoprolol,
nimesulide,furosemide,carbamazepine,ranitidine,metronidazole,paracetamol,andatorvastatin)fromseveraltherapeuticclasses
weresearchedin54samplingpointsalongtheriverPofromthesourcetothedelta,andatthemouthofitsmajoreﬄuents.Inwater
samples were found pharmaceuticals in the range of 0.38–0.001μg/L, except for furosemide (max conc. 0.605μg/L), paracetamol
(max conc. 3.59μg/L), metoprolol (never detected) and for atenolol (not analysed). In sediment samples, only paracetamol was
not detected, while the others were generally found in the range of 0.4–0.02μg/kg ww with high concentrations for atenolol (max
conc.284μg/kgww)andfurosemide(maxconc.98.4μg/kgww).TheﬁndingsconﬁrmalsoSTPsaspointsourcesofcontamination.
Despite of the much evidence for the adverse eﬀects of pharmaceuticals in the aquatic environment, the observed low levels cannot
be considered to pose a serious risk to human health; further studies are necessary for a comprehensive risk assessment.
1.Introduction
Today, one of the most relevant environmental issues is
the occurrence of pharmaceutically active substances in
surface waters, wastewater eﬄuents, and also sediments.
An important entry route of pharmaceuticals into the
environment is via conventional sewage-treatment plants
(STPs). It has been extensively shown [1–7] that STPs
are unable to completely remove contamination by phar-
maceuticals. For the majority of drugs, removal by con-
ventional biological treatments seems ineﬃcient, such that
contamination remains in the water eﬄuents [8–10]. A
recent study performed by Zuccato’s research group showed
that the total removal rate in STPs was generally lower
than 40% (http://www.cwwt.unsw.edu.au/ywp2006/papers/
YWP%20P.3.pdf “Behavior of pharmaceuticals in sewage
treatment plants”).
Pharmaceuticals, because of their continuous use and
entry into the environment, are considered as “pseudoper-
sistent compounds” [11]. They are introduced into the envi-
ronment into water and/or sewage through manufacturing
processes, improper disposal, and metabolic excreta, in the
form of parent compounds or as metabolites. In addition,
drugresidueshavebeenfoundintheterrestrialenvironment;
pharmaceuticals with acidic properties and high logKow,
mainlyantibiotics,showaﬃnitytosoil,sediment,andsludge
[12–14], in contrary to some drugs degradation that can be
promoted by microbial activity present in riverine or lagoon
sediments [14, 15], while their transport could be mediated
by colloids present in riverine water [16]. In this case, the
disposal of biosolids from STPs and animal wastes, which
are applied to land, represents the major inputs into the
environment [17, 18].
Evenifpharmaceuticalsareonlydetectedinwaterattrace
levels such as ng/L to low μg/L [19–22], these concentrations
may be of concern because these compounds are developed
to be biologically active [23]. Despite this increasing concern
about the possible impact of human pharmaceuticals on the
environment,therearenoregulationsinEuropeanlawwhich
set threshold values for drug residues in the environment.
The European Union has established a community
framework for water protection and management, with the2 Journal of Toxicology
Directive 2000/60/EC of the European Parliament and the
Council of 23rd October 2000. This Framework Directive
provides for the management of groundwater, inland surface
waters,andtransitionalandcoastalwatersinordertoprevent
pollution, to promote sustainable water use, to protect
the aquatic ecosystem, and to improve the status of the
aquatic environment. The European Union (EU) has also
designed a document in which a stepwise procedure for the
Environmental Risk Assessment (ERA) of pharmaceuticals is
established. This document has been revised several times
and was ﬁnally accepted and written as the guideline into
European law in June 2006 (guideline on the environmental
risk assessment of medicinal products for human use).
This guideline requires that “an application for the mar-
keting authorisation for a medicinal product for human use
shall be accompanied by an environmental risk assessment,”
in order to assess “those risks to the environment arising
from use, storage, and disposal of the medicinal product.”
The proposed ERA in this document is a two-tiered analysis
of potential environmental risk. Phase I should consist of an
estimateoftheexposureoftheenvironmenttoadrug,taking
into account the estimated yearly production, the market
penetration, and the predicted drug degradation in STPs and
itsfateintotheenvironment.PhaseII(dividedintotierAand
tier B) should establish drug physicochemical, toxicological,
and pharmacological properties. Phase II testing is required
for all substances with a predicted environmental concen-
tration (PEC) of 0.01μg/L or higher and/or with a speciﬁc
mode of action such as a direct or indirect interaction with a
receptor [24, 25].
Indeed the regulation has been endorsed water because
contamination occurred in diﬀerent countries. The presence
of pharmaceuticals in surface waters has been assessed in the
river Po basin by means of a voluntary initiative coordinated
by the Italian Civil Protection with our institute during
the years 2006 and 2007. The monitoring programme was
carried out in the river Po basin from Pian del Re (source) to
Porto Tolle (delta).
2. Experimental
2.1. Chemicals and Materials. Based on previously mentioned
investigations about the water quality of some rivers and
STP outlets in northern Italy measuring concentrations
of various pharmaceuticals, this research focused on the
following chemicals detected at least once previously:
atenolol, propanolol, metoprolol, nimesulide, furosemide,
carbamazepine, ranitidine, metronidazole, paracetamol, and
atorvastatin. The individual standard solutions of pharma-
ceuticals were prepared in pure methanol and stored at
−20◦C. Methanol and acetonitrile (chromatography grade)
were purchased from Merck (Italy). The active pharmaceuti-
cal ingredients were obtained from commercial products at
the concentrations certiﬁed on the label.
2.2. Sampling and Sample Preparation. Aqueous and sedi-
ment samples were collected from each sampling point, in
means of three subsamples for each point. Eighteen sampling
points were identiﬁed along the river Po starting from its
source and then downstream of the major urban areas or
immediately downstream of the conﬂuence of the eﬄuents
(Figure 1(a)). Particularly relevant because of their high ﬂow
rate or human density within their subbasins, 36 sampling
points were identiﬁed at the mouth of all the major Po
eﬄuents: within these, one was placed at the exit of an
urban STP (town of Cremona), and one was placed at the
conﬂuence with an artiﬁcial channel (Cavo Napoleonico)
connecting two hydrographical basins (Po and Reno basins)
(Figure 1(b)).
Both water and sediment samples were collected man-
ually in the centre of the stream section, sedimented by a
V a nV e e ns a m p l e r[ 26] or by hand/spade sampling where the
water depth was not too deep, and stored in polypropylene
bags, while water samples were collected in darkened-glass
bottles. All the samples were immediately refrigerated at 4◦C
during the transport to the laboratory and until extraction
and analysis.
Aqueous samples were extracted by solid phase extrac-
tion (SPE) cartridges and analysed by reversed-phase liquid
chromatography/mass spectrometry (HPLC-MS) [27]. Two
diﬀerent extractions by means of SPE cartridges were chosen
to ﬁnd a multiresidue method of extraction for pharmaceu-
ticals from a wide spectrum of chemical classes. Bond Elut
PPL (Superchrom, Italy) is designed for highly polar species
and for large-volume water samples (particle size of 125μm,
pore size of 150 ˚ A, and surface area of 600m2/g, functional
group: SDB—base deactivated silica). The discovery DSC-18
SPE tubes (Supelco, Italy), designed for less polar chemicals,
hadasilicagelandpolymericallybondedoctadecylwithhigh
carbon loading (18% C) sorbent matrix, with particle size of
50μm, pore size of 70 ˚ A ,a n das u r f a c ea r e ao f4 8 0m 2/g.
For the extraction, the PPL Bond Elut 3mL tubes and
Discovery DCS-18 6-mL tubes (500mg) were activated and
conditioned with methanol (6mL) and then ultrapure water
(12mL) with application of mild suction by a vacuum
manifold. Water samples (1000mL) were passed through the
cartridges at a ﬂow rate of 5mL/min. Sorbed analytes were
then eluted with acetonitrile (10mL) into a 10mL glass test
tube. The solvent was evaporated under a nitrogen stream
and redissolved in methanol (1mL), which solution was then
transferred to an autosampler vial for HPLC-MS analysis.
The extraction from sediments (50gww) was performed
via soxhlet apparatus by means of acetone as solvent
(200mL) followed by dehydration on sodium anhydrous
sulphate and reduction to small volume (1mL) by means of
Rotavapor an nitrogen ﬂux. The extract was then analysed
following the same procedure used to analyse water sample
extract.
2.3. HPLC/MS Determination. HPLC-MS analysis was per-
formed by a Thermo Electronic Corporate HPLC-MS with
a Surveyor MSQ Plus Finnigan single-quadrupole mass
detector operated in electrospray ionization (ESI) mode.
The HPLC was a Thermo quaternary pump with a degasser
and autosampler. The HPLC separation was performed
on a Phenomenex column, Synergi 4μm Hydro-RP 80(A)
150mm × 4.60mm id. The mobile phase was acetonitrileJournal of Toxicology 3
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Figure 1: Sampling points along river Po (a) and its tributaries (b).
and water with 0.1% of formic acid at a constant ﬂow
rate of 0.3mL/min. The analyses were done in ESI negative
for furosemide, nimesulide, and atorvastatin and in ESI
positive for the other compounds. For both methods, the
gradient of separation was 65:35% of water:acetonitrile
from 0min to 7min, increasing to 80% of acetonitrile over
25min, static at 80% of acetonitrile for 7min, decreasing
to 30% of acetonitrile over 3min, and static at 30:70% of
acetonitrile:water for 3min (38min total time). The MS
detector probe was set at 600◦C and the needle at 4kV
for the ESI positive method, whereas the probe was set at
570◦C for the ESI negative method. The detection of all
pharmaceuticalswasperformedinSIMforthequantiﬁcation
and full scan for the identiﬁcation. Data were acquired from
m/z 200 to 500. The software used for control, analysis, and
quantiﬁcation was Xcalibur 1.4.
Linearity was tested assessing signal responses of analytes
in standard solutions and in matrix extracts over a range
of concentrations from 0.001 up to 1.0mg/L (mg/kg).
Analytical signal of standard solution was compared with
the signal of a blank water extract spiked after extraction
with target compounds. Recoveries from water and sediment4 Journal of Toxicology
ranged from 65% to 80% for of the pharmaceuticals at the
two concentrations of 0.1 and 1.0mg/L (mg/kg). Recovery
for atenolol was assessed only in sediment within the range
described above.
2.4. CEC and OC Determinations. Cationic exchange capa-
bility was assessed according to the Barium chloride and
triethanolamine method [28], and organic carbon content
was assessed by ISO 14235 [29], Walkley-Black method.
3. Results andDiscussion
This work shows the results of a monitoring project of
10 pharmaceuticals in water and sediment collected in
2006 and 2007 in the basin of the Po river and all its
eﬄuents. The drugs for analysis were chosen so as to have
a variety of pharmaceuticals representative of prescription
and nonprescription classes, belonging in particular to
seven therapeutic classes: β-blockers, anti-inﬂammatories,
ulcer healers, diuretics, lipid-regulator agents, antiepileptics,
and antibiotics (Table 1) .D r u g sh a v eb e e ni n v e s t i g a t e dt o
understand if they might be accumulated in the aquatic
environment and pose a risk to living organisms. Most of the
previousresearchprojectscarriedoutintheareabyZuccato’s
research group focus only on pharmaceutical residues in
water samples, ground waters, or STP eﬄuents; therefore,
our choice of considering also sediment samples was done
to better understand the degree of accumulation resulting
from diﬀerent sources and trends. Due to limitations of
resources, the compounds investigated were the most used
and the most frequently detected in other European surveys.
In the ﬁrst year, preliminary screening was done on ﬁve
pharmaceuticals, whereas in the second year, the study was
extended to 10 pharmaceuticals. As reported in Table 1,
these pharmaceuticals span a wide range of physicochemical
properties.
The Po river basin is the largest and the most important
in Italy, covering an area of 74,000km2 [30, 31]. The Po area
is a strategic region for the Italian economy, with signiﬁcant
agriculture, livestock, industry, and tourism, and it collects
sewage from a vast industrialized area of northern Italy that
represents an intense and continuous loading into the STP
system(Figure2)andsubsequentemission.Therefore,itmay
be considered the worst realistic and representative Italian
scenario to estimate the level of contamination in surface-
water bodies.
Table 2 indicates the pharmaceuticals concentration
found in water and sediments, including the cationic
exchange capability and the organic carbon content.
Amongst the 10 pharmaceuticals of interest, two (atenolol
and metoprolol) were not detected in the water samples.
Most pharmaceuticals were found in the range of 0.38–
0.001μg/L,exceptforfurosemide(maxconc.0.605μg/L)and
paracetamol which was detected at higher concentrations in
almost all samples (max conc. 3.59μg/L) (Table 2).
In sediment samples, only paracetamol was not detected,
while the others were generally found in the range of 0.4–
0.02μg/kg. High concentrations were found in sediment
samples for atenolol (max conc. 284μg/kg) and furosemide
(max conc. 98.4μg/kg).
These results might indicate a correlation between con-
centration and the physicochemical properties of the drugs,
inparticulartheirlogKow.Chemicalcompoundswithhigher
Kow show greater aﬃnity to hydrophobic matrices rather
than to water. So, it might be predicted that pharmaceuticals
such as atorvastatin, nimesulide, furosemide, and ranitidine
are more concentrated in sediment samples, whereas our
investigation indicates atenolol (log Kow:0.5) as the principal
drug residue in sediments. In addition, paracetamol, which
has a similar log Kow (0.46), was never detected in sediment
samples. On the basis of the observed results, plotting
maximum concentration (Cmax.)o fp h a r m a c e u t i c a l sv e r s u s
log Kow showed no relationship between concentration and
log Kow. This is in agreement with the ﬁndings in [32,
33] and may be due to the historical accumulation of
pharmaceuticals in the sediment as well as the characteristics
of the sources of the contamination. STP inlet contaminates
water discontinuously in time, and space while in parallel
sediment burrow along the river can produce heterogeneous
contamination of the sediment.
All the sediments showed concentrations of most phar-
maceuticals higher than 0.01μg/kg (except paracetamol),
and in water samples in most cases, with the exceptions of
atenolol and metoprolol, the concentrations found exceeded
the threshold value set by European Medicines Agency
(EMEA) [24] for water (0.01μg/kg). Such concentrations
appearedtobeinboththematrices,beingcorrelatedwiththe
population living around each sampling point and with the
characteristics of the STPs. In sediments from the Po eﬄu-
ents, atenolol was found at high concentration (108μg/kg)
corresponding to the conﬂuence with the Orco river, around
which there is a population of 69854 inhabitants, and nearby
STPs have a total nominal load of 45.000 inhabitants.A
concentration of 61μg/kg of atenolol was detected in the
Chisola river, probably because of nearby STPs with a big
nominal load (ca. 314500 inhabitants) which release their
eﬄuents. Surprisingly, a low amount of atenolol of 30μg/kg
wasfoundin Adda basin, inspite of ca.1.687.000 inhabitants
living around. This can be explained considering the nearest
sampling point along the Po river (Monticelli), where the
highest atenolol concentration was detected (283μg/kg).
These results conﬁrm atenolol as a priority pollutant [34].
Atenolol was not found in all water samples. A similar
result was recently obtained by Kuster et al. [35]i nt w o
pilot monitoring studies in the Llobregat river basin. For
furosemide, the high concentration detected in sediments
sampled at the conﬂuence with the Sesia river (98.42μg/kg)
could be strange compared with the concentration found
at Monticelli d’Ongina (17.81μg/kg) considering only the
populations living around (ca. 632100 for the ﬁrst one
and ca. 500000 for the second one); however, this can be
explained because of the presence of an STP with a big
nominal load (100000) at 20km distance from the sampling
point on the Sesia river.
Despite the above two observations, it was quite diﬃcult
to observe a correlation between the concentration or the
number of pharmaceuticals detected at each sampling pointJournal of Toxicology 5
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Figure 2: Inhabitant distribution (a) and sewage plants distribution (b) in river Po basin and its subbasins.6 Journal of Toxicology
Table 1: Literature values (S. Castiglioni et al., 2004; R. Andreozzi et al., 2003; Banca dati Farmacoambiente; Drugbank) of the physico-
chemical properties and degradation behaviour of the selected pharmaceuticals.
Class of drugs Pharmaceutical Molecular weight
(g/mol) Log Kow Stability in water
β-Blocker Atenolol 266.3 0.5 Stable for 40d (5–25◦C)
t50 45.2h pH 7.4 (UV ray)
Moderate
stability
Anti-
inﬂammatory
Paracetamol 151.16 0.46 (experim.)
0.27 (predicted)
Nimesulide 308.3 2.56
Metoprolol 267 0.5
Propranolol 259 3.65
Ulcer healing Ranitidine 314.4 1.3 (experim.) Stable 160h pH
6.18,65◦C
Prolonged
stability 0.79 (predicted)
Diuretic Furosemide 330.7 1.4 (experim.) Stable 90d pH 5.2 Prolonged
stability 2.71 (predicted) Stable 96% 240d pH 5.2
Lipid regulator Atorvastatin 558.6 5.7 (experim.)
4.24 (predicted)
Antiepileptic Carbamazepine 236 2.3 (experim.) t50 100d Prolonged
stability 2.10 (predicted)
Antibacterial Metronidazole 171
−0.1 (experim.)
−0.15 (predicted)
andthepopulationandSTP’snominalloadaroundasshown
in Figure 3 in which number of pharmaceuticals is reported
per each sampling point along the Po river and its eﬄuents,
ordered by increasing population. A similar situation is
observed if plotting number of drugs and sampling points
ordered by increasing STP’s nominal load.
To have an idea of the removal rate eﬃciency by STPs,
waters sampled at Cremona city (sampling point H) can be
considered. Their drug content is 0.079μg/L of paracetamol.
On the other hand, waters coming out of Cremona STP
(sampling point 15) contain carbamazepine, nimesulide
and also a higher amount of paracetamol (0.486μg/L),
indicating that STPs can sometimes act as sources of point
contamination (Table 2).
In Figure 3, the number of detected pharmaceuticals per
sampling point along the Po river both in sediment and in
water samples is reported. Considering water samples, the
number of drugs generally increased in sampling points near
the Po delta (from O to T), with a maximum value at the
O site (Berra-Papozze). In contrast, it was not possible to
observe any trend in the distribution of pharmaceuticals in
water samples from the Po eﬄuents.
4. Conclusions
This work presents the results of a voluntary monitoring
project carried out in two consecutive years (2006-2007)
in the most important Italian river basin with the aim to
give a preliminary survey of the level of pharmaceutical
contamination and accumulation in surface waters and
sediments.
Of the 10 pharmaceuticals from several therapeutic
classes, two (atenolol and metoprolol) were never detected
inwatersamples;otherdrugswereatlevelsbelow100ng/Lin
mostinstances.Thisisinagreementwithﬁndingsinwaterof
previous investigations performed in small parts of the same
region. The levels of pharmaceuticals detected in sediment
samples were generally higher (in the range of μg/kg), in
particular for atenolol and furosemide.
Indeed no satisfactory correlation was observed between
the environmental concentration and the distribution of
pharmaceuticals and the resident population or the STPs’
nominal loads around each sampling point; the ﬁndings
conﬁrm STPs as point sources of contamination and a
discontinuous accumulation in the sediment.
Despite much evidence for the adverse eﬀects of phar-
maceuticals in the aquatic environment, the observed low
levels cannot be considered to pose a serious risk to human
health; further studies are necessary for a comprehensive risk
assessmentbecausetheresidentpopulationcouldbeexposed
by multiple sources such as irrigation, drinking, recreational,
andfooduses.Inaddition,thesynergisticeﬀectsofamixture
of diﬀerent compound classes are still unknown [11, 27, 36].
As noted, the Po river represents the most important Italian
river basin because of its dimensions of the population
living in and the economic activities performed in the basin.
Water from the Po river is used for industrial purposes,
in recreational facilities, in agriculture (for irrigation and
cattle),inaquacultureplants,inparticularintheareaaround
Po delta, and almost along the entire basin surface, and
ground waters represent an important source of drinking
water (particularly around the cities of Ferrara and Rovigo)
[37]. As an example, one of the biggest puriﬁcation plants
for drinking water is located at Pontelagoscuro (in our
investigation sampling point N); in water sampled here,
only one pharmaceutical was detected and that was atJournal of Toxicology 7
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Figure 3: Number of compounds detected in water (a) and sediment (b) samples collected in river Po basin and its tributaries.10 Journal of Toxicology
lowconcentration(carbamazepine0.021μg/L).However,the
level of pharmaceutical contamination is almost the same at
SaccadiGoro(samplingpointS),oneofthemostproductive
systems of clam farming in Italy, where also two other phar-
maceuticals (atorvastatin and furosemide) were detected at
levels of 0.023–0.027μg/L. A recent study, conducted at the
r i v e rP od e l t a ,[ 37] indicates that pharmaceuticals could be
found in drinking water and how puriﬁcation plants can
be more eﬃcient only if structured with new modules as
granular-active carbon stage.
From these concerns is therefore foreseen a need to
further assess if the pharmaceuticals detected in Po river
waters would pose any risk for human health as well as for
the terrestrial and aquatic organisms living in the basin.
References
[1] M. D. Hernando, M. Mezcua, M. J. G´ omez, O. Malato,
A. Ag¨ uera, and A. R. Fern´ andez-Alba, “Comparative study
of analytical methods involving gas chromatography-mass
spectrometry after derivatization and gas chromatography-
tandem mass spectrometry for the determination of selected
endocrine disrupting compounds in wastewaters,” Journal of
Chromatography A, vol. 1047, no. 1, pp. 129–135, 2004.
[2] S. Castiglioni, R. Bagnati, D. Calamari, R. Fanelli, and
E. Zuccato, “A multiresidue analytical method using solid-
phase extraction and high-pressure liquid chromatography
tandem mass spectrometry to measure pharmaceuticals of
diﬀerent therapeutic classes in urban wastewaters,” Journal of
Chromatography A, vol. 1092, no. 2, pp. 206–215, 2005.
[3] S. Castiglioni, R. Fanelli, D. Calamari, R. Bagnati, and E. Zuc-
cato, “Methodological approaches for studying pharmaceuti-
calsintheenvironmentbycomparingpredictedandmeasured
concentrations in River Po, Italy,” Regulatory Toxicology and
Pharmacology, vol. 39, no. 1, pp. 25–32, 2004.
[4] M. Stumpf, T. A. Ternes, R. D. Wilken, S. V. Rodrigues, and W.
Baumann, “Polar drug residues in sewage and natural waters
i nt h es t a t eo fR i od eJ a n e i r o ,B r a z i l , ”Science of the Total
Environment, vol. 225, no. 1-2, pp. 135–141, 1999.
[5] C. D. Metcalfe, B. G. Koenig, D. T. Bennie, M. Servos, T.
A. Ternes, and R. Hirsch, “Occurrence of neutral and acidic
drugs in the eﬄuents of canadian sewage treatment plants,”
Environmental Toxicology and Chemistry, vol. 22, no. 12, pp.
2872–2880, 2003.
[6] A. C. Johnson and J. P. Sumpter, “Removal of endocrine-
disrupting chemicals in activated sludge treatment works,”
Environmental Science and Technology, vol. 35, no. 24, pp.
4697–4703, 2001.
[ 7 ]M .C a r b a l l a ,F .O m i l ,J .M .L e m ae ta l . ,“ B e h a v i o ro fp h a r -
maceuticals, cosmetics and hormones in a sewage treatment
plant,” Water Research, vol. 38, no. 12, pp. 2918–2926, 2004.
[8] T. A. Ternes, “Occurrence of drugs in German sewage
treatment plants and rivers,” Water Research, vol. 32, no. 11,
pp. 3245–3260, 1998.
[9] E. M. Golet, A. C. Alder, A. Hartmann, T. A. Temes, and W.
Giger, “Trace determination of ﬂuoroquinolone antibacterial
agents in urban wastewater by solid-phase extraction and liq-
uid chromatography with ﬂuorescence detection,” Analytical
Chemistry, vol. 73, no. 15, pp. 3632–3638, 2001.
[10] REMPHARMAWATER, Project for ecotoxicological assessments
and removal technologies for pharmaceuticals in wastewaters,
contract number EVK1-CT2000-00048.
[11] M. D. Hernando, M. Mezcua, A. R. Fern´ andez-Alba, and D.
Barcel´ o, “Environmental risk assessment of pharmaceutical
residues in wastewater eﬄuents, surface waters and sedi-
ments,” Talanta, vol. 69, no. 2, pp. 334–342, 2006.
[12] J. Beausse, “Selected drugs in solid matrices: a review of
environmental determination, occurrence and properties of
principal substances,” Trends in Analytical Chemistry, vol. 23,
no. 10-11, pp. 753–761, 2004.
[13] S. Thiele-Bruhn, “Pharmaceutical antibiotic compounds in
soils—a review,” Journal of Plant Nutrition and Soil Science,
vol. 166, no. 2, pp. 145–167, 2003.
[14] D. L¨ oﬄer, J. R¨ ombke, M. Meller, and T. A. Ternes, “Environ-
mental fate of pharmaceuticals in water/sediment systems,”
Environmental Science and Technology, vol. 39, no. 14, pp.
5209–5218, 2005.
[15] M. L. Sacc` a, C. Accinelli, J. Fick, R. Lindberg, and B. Olsen,
“Environmental fate of the antiviral drug Tamiﬂu in two
aquatic ecosystems,” Chemosphere, vol. 75, no. 1, pp. 28–33,
2009.
[16] Y.Yang,J.Fu,H.Peng,L.Hou,M.Liu,andJ.L.Zhou,“Occur-
rence and phase distribution of selected pharmaceuticals in
the Yangtze Estuary and its coastal zone,” Journal of Hazardous
Materials, vol. 190, no. 1–3, pp. 588–596, 2011.
[17] B. Halling-Sørensen, S. Nors Nielsen, P. F. Lanzky, F. Inger-
slev, H. C. Holten L¨ utzhøft, and S. E. Jørgensen, “Occur-
rence, fate and eﬀects of pharmaceutical substances in the
environment—a review,” Chemosphere,vol.36,no.2,pp.357–
393, 1998.
[18] M. S. D´ ıaz-Cruz, M. J. L´ opez de Alda, and D. Barcel´ o, “Envi-
ronmental behavior and analysis of veterinary and human
drugs in soils, sediments and sludge,” Trends in Analytical
Chemistry, vol. 22, no. 6, pp. 340–351, 2003.
[19] D. Calamari, E. Zuccato, S. Castiglioni, R. Bagnati, and R.
Fanelli, “Therapeutic drugs in the river Po and Lambro in
Northern Italy: a strategic survey,” Environmental Science and
Technology, vol. 37, no. 7, pp. 1241–1248, 2003.
[20] R. Hirsch, T. Ternes, K. Haberer, and K.-L. Kratz, “Occurrence
of antibiotics in the aquatic environment,” Science of the Total
Environment, vol. 225, no. 1-2, pp. 109–118, 1999.
[ 2 1 ]C .T i x i e r ,H .P .S i n g e r ,S .O e l l e r s ,a n dS .R .M ¨ uller, “Occur-
rence and fate of carbamazepine, cloﬁbric acid, diclofenac,
ibuprofen, ketoprofen, and naproxen in surface waters,”
EnvironmentalScienceandTechnology,vol.37,no.6,pp.1061–
1068, 2003.
[22] S. Weigel, J. Kuhlmann, and H. H¨ uhnerfuss, “Drugs and
personal care products as ubiquitous pollutants: occurrence
and distribution of cloﬁbric acid, caﬀeine and DEET in the
North Sea,” Science of the Total Environment, vol. 295, no. 1-2,
pp. 131–141, 2002.
[23] J.P.BoundandN.Voulvoulis,“Pharmaceuticalsintheaquatic
environment: a comparison of risk assessment strategies,”
Chemosphere, vol. 56, no. 11, pp. 1143–1155, 2004.
[24] EMEA, “Guidelines on the Environmental Risk Assess-
ment of Medicinal Products for Human Use (Doc. Ref.
EMEA/CHMP/SWP/447/00),” 2006.
[25] E. O’ Brien and D. Dietrich, “Characterization of microcystin
production in an Antarctic cyanobacterial mat community,”
Trends in Biotechnology, vol. 22, no. 3, pp. 326–330, 2004.
[26] R.L.Wigley,“ComparativeeﬃcienciesofvanVeenandSmith-
Mclntyre grab samplers as revealed by motion pictures,”
Ecology, vol. 48, pp. 168–169, 1967.
[27] M. J. G´ omez, M. Petrovi´ c, A. R. Fern´ andez-Alba, and
D. Barcel´ o, “Determination of pharmaceuticals of various
therapeutic classes by solid-phase extraction and liquidJournal of Toxicology 11
chromatography-tandem mass spectrometry analysis in hos-
pital eﬄuent wastewaters,” Journal of Chromatography A, vol.
1114, no. 2, pp. 224–233, 2006.
[28] R. Dohrmann, “Cation exchange capacity methodology I:
an eﬃcient model for the detection of incorrect cation
exchange capacity and exchangeable cation results,” Applied
Clay Science, vol. 34, no. 1–4, pp. 31–37, 2006.
[29] ISO, “Soil quality—determination of organic carbon by
sulfochromic oxidation,” 5 Pages, 1998.
[30] Autorit` a di Bacino del ﬁume Po, “Caratteristiche del Bacino
del ﬁume Po e primo esame dell’impatto ambientale delle
attivit` a umane sulle risorse idriche,” Monography, 643 pages,
2006.
[31] Autorit` a di Bacino del ﬁume Po, “Atlante geomorfologico del
ﬁume Po,” Monography, 97 pages, 2009.
[32] P.K.Jjemba,“Excretionandecotoxicityofpharmaceuticaland
personal care products in the environment,” Ecotoxicology and
Environmental Safety, vol. 63, no. 1, pp. 113–130, 2006.
[33] E. R. Cooper, T. C. Siewicki, and K. Phillips, “Preliminary risk
assessment database and risk ranking of pharmaceuticals in
the environment,” Science of the Total Environment, vol. 398,
no. 1–3, pp. 26–33, 2008.
[34] E. Zuccato, S. Castiglioni, and R. Fanelli, “Identiﬁcation of
the pharmaceuticals for human use contaminating the Italian
aquatic environment,” Journal of Hazardous Materials, vol.
122, no. 3, pp. 205–209, 2005.
[35] M. Kuster, M. J. L´ opez de Alda, M. D. Hernando, M. Petrovic,
J. Mart´ ın-Alonso, and D. Barcel´ o, “Analysis and occurrence of
pharmaceuticals, estrogens, progestogens and polar pesticides
in sewage treatment plant eﬄuents, river water and drinking
water in the Llobregat river basin (Barcelona, Spain),” Journal
of Hydrology, vol. 358, no. 1-2, pp. 112–123, 2008.
[36] C. G. Daughton and T. A. Ternes, “Pharmaceuticals and
personal care products in the environment: agents of subtle
change?” Environmental Health Perspectives, vol. 107, supple-
ment 6, pp. 907–938, 1999.
[37] G. Pojana, A. Fantinati, and A. Marcomini, “Occurrence of
environmentally relevant pharmaceuticals in Italian drinking
water treatment plants,” International Journal of Environmen-
tal Analytical Chemistry, vol. 91, no. 6, pp. 537–552, 2011.